Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
TEN1 is a key component of the CST complex (CTC1-STN1-TEN1) responsible for regulating telomere length and facilitating DNA replication at chromosome ends[2][10]. In mammals, TEN1 supports C-strand synthesis after telomerase activity and is critical for telomere duplex replication and genome-wide replication restart[1][6][10]. TEN1 forms a stable protein complex with STN1 and CTC1, with all subunits contributing to telomere homeostasis but playing distinct roles. While CTC1 and STN1 are essential for limiting telomerase activity, TEN1 stabilizes CST complex binding to single-stranded DNA and is required for the fill-in synthesis of the complementary strand[1][6]. Disruption of TEN1 function leads to telomere shortening, chromosomal instability, and compromised cellular proliferation, underscoring its importance in genome maintenance[6][4]. Although highly relevant for fundamental telomere biology and implicated in tumor cell survival mechanisms, TEN1 itself has not been established as a direct therapeutic target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Telomere length regulation protein TEN1 homolog (TEN1).